Synergic Medical Technologies

Executive Summary

Synergic Medical Technologies is a private San Diego-based company developing non-invasive neuromodulation therapies for Parkinson's disease. The company's research focuses on understanding how Parkinson's alters brain activity and applying targeted electrical or magnetic stimulation to restore normal function and alleviate symptoms. Unlike invasive deep brain stimulation, Synergic's approach aims to offer a safer, more accessible alternative with fewer side effects. The company was founded in 2017 and is in the preclinical development stage, with no disclosed funding or valuation. Its technology addresses a significant unmet need, as Parkinson's affects over 10 million people worldwide and current treatments lose efficacy over time. Synergic's platform could potentially serve as an early-intervention therapy or be used in combination with existing medications. The company's progress toward clinical validation will be critical for future valuation and partnership opportunities.

Upcoming Catalysts (preview)

• TBDInitiation of first-in-human clinical trial for lead neuromodulation device30% success
• TBDPresentation of preclinical data demonstrating symptom relief in animal models60% success
• TBDStrategic partnership with a major Parkinson's research center or pharmaceutical company25% success